Conference Coverage (Retrovirus)
New Drug Clinically Active Against Both HIV and CMV
Published in Hepatitis Weekly, February 19th, 1996
The drug, bis-POM-9-(2-phosphonylmethoxyethly)adenine (bisPOM PMEA), is a prodrug that the body converts into its parent compound, PMEA or adefovir (code name GS 393). PMEA itself has poor oral bioavailability, but is exquisitely active against HIV in laboratory studies.
The drug's manufacturer, Gilead Sciences Inc., Foster City, California, has dubbed the new compound adefovir dipivoxil (code name GS 840).
Laboratory studies also showed that both drugs are active against...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-02-19)
More Articles from Hepatitis Weekly
- Conference Coverage (ISVH)
IFN Response Predictors Assessed at Madrid Meeting - Conference Coverage (ISVH)
ALT Not Reliable in Hepatitis Evaluation During Pregnancy - Conference Coverage (ISVH)
Does HIV Infection Lower IFN Response? - Conference Coverage (ISVH)
Dual HBV/HCV Infection Suggests Aggressive Liver Disease - Conference Coverage (ISVH)
HBV Vaccine Can Easily Be Combined with DPT - Conference Coverage (ISVH)
More Aggressive Chronic HCV Seen in Transfused Patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
